• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三阴性乳腺癌中p53表达与肿瘤浸润淋巴细胞数量的相关性

Association between p53 Expression and Amount of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.

作者信息

Lee Miseon, Park In Ah, Heo Sun-Hee, Kim Young-Ae, Gong Gyungyub, Lee Hee Jin

机构信息

Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Asan Center for Cancer Genome Discovery, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

出版信息

J Pathol Transl Med. 2019 May;53(3):180-187. doi: 10.4132/jptm.2019.02.08. Epub 2019 Mar 11.

DOI:10.4132/jptm.2019.02.08
PMID:30853706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6527934/
Abstract

BACKGROUND

Most triple-negative breast cancers (TNBCs) have a high histologic grade, are associated with high endoplasmic stress, and possess a high frequency of TP53 mutations. TP53 missense mutations lead to the production of mutant p53 protein and usually show high levels of p53 protein expression. Tumor-infiltrating lymphocytes (TILs) accumulate as part of the anti-tumor immune response and have a strong prognostic and predictive significance in TNBC. We aimed to elucidate the association between p53 expression and the amount of TILs in TNBC.

METHODS

In 678 TNBC patients, we evaluated TIL levels and expression of endoplasmic stress molecules. Immunohistochemical examination of p53 protein expression was categorized into three groups: no, low, and high expression.

RESULTS

No, low, and high p53 expression was identified in 44.1% (n = 299), 20.1% (n = 136), and 35.8% (n = 243) of patients, respectively. Patients with high p53 expression showed high histologic grade (p < .001), high TIL levels (p = .009), and high expression of endoplasmic reticulum stress-associated molecules (p-eIF2a, p = .013; XBP1, p = .007), compared to patients with low p53 expression. There was no significant difference in disease-free (p = .406) or overall survival rates (p = .444) among the three p53 expression groups.

CONCLUSIONS

High p53 expression is associated with increased expression of endoplasmic reticulum stress molecules and TIL influx.

摘要

背景

大多数三阴性乳腺癌(TNBC)具有高组织学分级,与内质网应激水平升高相关,且TP53突变频率较高。TP53错义突变导致突变型p53蛋白的产生,通常表现为p53蛋白高表达。肿瘤浸润淋巴细胞(TILs)作为抗肿瘤免疫反应的一部分而积聚,在TNBC中具有很强的预后和预测意义。我们旨在阐明TNBC中p53表达与TILs数量之间的关联。

方法

在678例TNBC患者中,我们评估了TILs水平和内质网应激分子的表达。p53蛋白表达的免疫组化检查分为三组:无表达、低表达和高表达。

结果

分别在44.1%(n = 299)、20.1%(n = 136)和35.8%(n = 243)的患者中发现了p53无表达、低表达和高表达。与p53低表达的患者相比,p53高表达的患者表现出高组织学分级(p <.001)、高TILs水平(p =.009)和内质网应激相关分子的高表达(p-eIF2a,p =.013;XBP1,p =.007)。三个p53表达组之间的无病生存率(p =.406)或总生存率(p =.444)没有显著差异。

结论

p53高表达与内质网应激分子表达增加和TILs浸润增加相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc0/6527934/271bae12749d/jptm-2019-02-08f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc0/6527934/b96cb5a5d260/jptm-2019-02-08f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc0/6527934/2dc2488ca65f/jptm-2019-02-08f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc0/6527934/25c65e99c4c9/jptm-2019-02-08f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc0/6527934/359a4d4d47f6/jptm-2019-02-08f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc0/6527934/271bae12749d/jptm-2019-02-08f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc0/6527934/b96cb5a5d260/jptm-2019-02-08f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc0/6527934/2dc2488ca65f/jptm-2019-02-08f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc0/6527934/25c65e99c4c9/jptm-2019-02-08f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc0/6527934/359a4d4d47f6/jptm-2019-02-08f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc0/6527934/271bae12749d/jptm-2019-02-08f5.jpg

相似文献

1
Association between p53 Expression and Amount of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.三阴性乳腺癌中p53表达与肿瘤浸润淋巴细胞数量的相关性
J Pathol Transl Med. 2019 May;53(3):180-187. doi: 10.4132/jptm.2019.02.08. Epub 2019 Mar 11.
2
Endoplasmic reticulum stress induces secretion of high-mobility group proteins and is associated with tumor-infiltrating lymphocytes in triple-negative breast cancer.内质网应激诱导高迁移率族蛋白的分泌,并与三阴性乳腺癌中的肿瘤浸润淋巴细胞相关。
Oncotarget. 2016 Sep 13;7(37):59957-59964. doi: 10.18632/oncotarget.11010.
3
The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC).免疫检查点抑制剂的治疗候选物由三阴性乳腺癌(TNBC)中肿瘤浸润淋巴细胞(TILs)和程序性死亡配体 1(PD-L1)表达的状态所阐明。
Breast Cancer. 2018 Jan;25(1):34-42. doi: 10.1007/s12282-017-0781-0. Epub 2017 May 9.
4
Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.三阴性乳腺癌新辅助化疗后残留肿瘤中肿瘤浸润性CD8 +和FOXP3 +淋巴细胞的预后意义及这些参数的变化:一项回顾性多中心研究
Breast Cancer Res. 2015 Sep 4;17(1):124. doi: 10.1186/s13058-015-0632-x.
5
Cytoplasmic expression of high mobility group B1 (HMGB1) is associated with tumor-infiltrating lymphocytes (TILs) in breast cancer.高迁移率族蛋白B1(HMGB1)的细胞质表达与乳腺癌中的肿瘤浸润淋巴细胞(TILs)相关。
Pathol Int. 2016 Apr;66(4):202-9. doi: 10.1111/pin.12393. Epub 2016 Feb 27.
6
Tumor-infiltrating lymphocytes are significantly associated with better overall survival and disease-free survival in triple-negative but not estrogen receptor-positive breast cancers.肿瘤浸润淋巴细胞与三阴性乳腺癌而非雌激素受体阳性乳腺癌的更好的总生存期和无病生存期显著相关。
Hum Pathol. 2017 Jun;64:7-12. doi: 10.1016/j.humpath.2017.01.004. Epub 2017 Jan 30.
7
MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer.MxA表达与肿瘤浸润淋巴细胞相关,是三阴性乳腺癌的一个预后因素。
Breast Cancer Res Treat. 2016 Apr;156(3):597-606. doi: 10.1007/s10549-016-3786-z. Epub 2016 Apr 13.
8
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.浸润淋巴细胞与不同亚型乳腺癌患者预后的关系:新辅助化疗治疗 3771 例患者的汇总分析
Lancet Oncol. 2018 Jan;19(1):40-50. doi: 10.1016/S1470-2045(17)30904-X. Epub 2017 Dec 7.
9
Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy.TP53突变在接受新辅助蒽环类/紫杉类化疗的三阴性和HER2阳性乳腺癌中的作用。
Oncotarget. 2016 Oct 18;7(42):67686-67698. doi: 10.18632/oncotarget.11891.
10
Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy.肿瘤浸润淋巴细胞及拓扑异构酶IIα表达在紫杉烷-蒽环类新辅助化疗后三阴性乳腺癌患者临床结局预测中的意义
Chemotherapy. 2017;62(4):246-255. doi: 10.1159/000470900. Epub 2017 May 5.

引用本文的文献

1
GD3 synthase drives resistance to p53-induced apoptosis in breast cancer by modulating mitochondrial function.GD3合酶通过调节线粒体功能,驱动乳腺癌对p53诱导的细胞凋亡产生抗性。
Oncogene. 2025 May 17. doi: 10.1038/s41388-025-03432-x.
2
Correlating p53 immunostaining patterns with somatic TP53 mutation and functional properties of mutant p53 in triple-negative breast cancer.三阴乳腺癌中p53免疫染色模式与体细胞TP53突变及突变型p53功能特性的相关性
Histopathology. 2025 Aug;87(2):299-309. doi: 10.1111/his.15453. Epub 2025 Mar 31.
3
The search for a TNBC vaccine: the guardian vaccine.

本文引用的文献

1
New Insights into the Role of Endoplasmic Reticulum Stress in Breast Cancer Metastasis.内质网应激在乳腺癌转移中作用的新见解
J Breast Cancer. 2018 Dec;21(4):354-362. doi: 10.4048/jbc.2018.21.e51. Epub 2018 Nov 23.
2
Reproducible evaluation of tumor-infiltrating lymphocytes (TILs) using the recommendations of International TILs Working Group 2014.依据国际肿瘤浸润淋巴细胞工作组2014年的建议对肿瘤浸润淋巴细胞(TILs)进行可重复性评估。
Ann Diagn Pathol. 2018 Aug;35:77-79. doi: 10.1016/j.anndiagpath.2018.05.007. Epub 2018 May 31.
3
Expression of the MHC class II in triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and interferon signaling.
三阴性乳腺癌疫苗的探索:守护者疫苗。
Cancer Biol Ther. 2025 Dec;26(1):2472432. doi: 10.1080/15384047.2025.2472432. Epub 2025 Mar 15.
4
Updated Austrian treatment algorithm for metastatic triple-negative breast cancer.转移性三阴性乳腺癌的奥地利更新治疗算法。
Wien Klin Wochenschr. 2024 Jun;136(11-12):347-361. doi: 10.1007/s00508-023-02254-9. Epub 2023 Sep 8.
5
Prognostic benefit of TILs independent of clinicopathological and molecular factors.肿瘤浸润淋巴细胞(TILs)的预后益处独立于临床病理和分子因素。
Br J Cancer. 2023 Sep;129(5):737-738. doi: 10.1038/s41416-023-02335-6. Epub 2023 Jul 13.
6
Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy.三阴性乳腺癌:免疫原性、肿瘤微环境与免疫治疗
Front Genet. 2023 Jan 12;13:1095839. doi: 10.3389/fgene.2022.1095839. eCollection 2022.
7
The tumor microenvironment and triple-negative breast cancer aggressiveness: shedding light on mechanisms and targeting.肿瘤微环境与三阴性乳腺癌的侵袭性:揭示机制与靶向治疗。
Expert Opin Ther Targets. 2022 Dec;26(12):1041-1056. doi: 10.1080/14728222.2022.2170779. Epub 2023 Jan 29.
8
Crosstalk between Immune Checkpoint Modulators, Metabolic Reprogramming and Cellular Plasticity in Triple-Negative Breast Cancer.免疫检查点调节剂、代谢重编程与三阴性乳腺癌细胞可塑性之间的串扰。
Curr Oncol. 2022 Sep 23;29(10):6847-6863. doi: 10.3390/curroncol29100540.
9
Prognostic analysis of cuproptosis-related gene in triple-negative breast cancer.铜死亡相关基因在三阴性乳腺癌中的预后分析。
Front Immunol. 2022 Aug 1;13:922780. doi: 10.3389/fimmu.2022.922780. eCollection 2022.
10
Dihydroartemisinin-Transferrin Adducts Enhance TRAIL-Induced Apoptosis in Triple-Negative Breast Cancer in a P53-Independent and ROS-Dependent Manner.双氢青蒿素-转铁蛋白加合物以不依赖P53和依赖ROS的方式增强TRAIL诱导的三阴性乳腺癌细胞凋亡。
Front Oncol. 2022 Jan 3;11:789336. doi: 10.3389/fonc.2021.789336. eCollection 2021.
三阴性乳腺癌中MHC II类分子的表达与肿瘤浸润淋巴细胞及干扰素信号传导相关。
PLoS One. 2017 Aug 17;12(8):e0182786. doi: 10.1371/journal.pone.0182786. eCollection 2017.
4
Mutant p53 as a target for cancer treatment.突变型p53作为癌症治疗的靶点。
Eur J Cancer. 2017 Sep;83:258-265. doi: 10.1016/j.ejca.2017.06.023. Epub 2017 Jul 28.
5
Picrasidine G decreases viability of MDA-MB 468 EGFR-overexpressing triple-negative breast cancer cells through inhibition of EGFR/STAT3 signaling pathway.苦树素G通过抑制EGFR/STAT3信号通路降低过表达EGFR的MDA-MB 468三阴性乳腺癌细胞的活力。
Bioorg Med Chem Lett. 2017 Jun 1;27(11):2608-2612. doi: 10.1016/j.bmcl.2017.03.061. Epub 2017 Mar 23.
6
Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician.癌症的分子靶向治疗:核医学医师指南
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):41-54. doi: 10.1007/s00259-017-3695-3. Epub 2017 Apr 10.
7
Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy.癌症中的突变型p53:积累、功能获得与治疗
J Mol Biol. 2017 Jun 2;429(11):1595-1606. doi: 10.1016/j.jmb.2017.03.030. Epub 2017 Apr 6.
8
Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy.TP53突变在接受新辅助蒽环类/紫杉类化疗的三阴性和HER2阳性乳腺癌中的作用。
Oncotarget. 2016 Oct 18;7(42):67686-67698. doi: 10.18632/oncotarget.11891.
9
Gene Coexpression Analyses Differentiate Networks Associated with Diverse Cancers Harboring TP53 Missense or Null Mutations.基因共表达分析区分与携带TP53错义或无效突变的多种癌症相关的网络。
Front Genet. 2016 Aug 3;7:137. doi: 10.3389/fgene.2016.00137. eCollection 2016.
10
Endoplasmic reticulum stress induces secretion of high-mobility group proteins and is associated with tumor-infiltrating lymphocytes in triple-negative breast cancer.内质网应激诱导高迁移率族蛋白的分泌,并与三阴性乳腺癌中的肿瘤浸润淋巴细胞相关。
Oncotarget. 2016 Sep 13;7(37):59957-59964. doi: 10.18632/oncotarget.11010.